N
This company develops nanotechnology-based drug delivery systems to transport therapeutics across the blood-brain barrier. Their technology enables the delivery of biologics and RNA drugs directly into the brain, improving treatment options for central nervous system disorders.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- This company develops nanotechnology-based drug delivery systems to transport therapeutics across the blood-brain barrier. Their technology enables the delivery of biologics and RNA drugs directly into the brain, improving treatment options for central nervous system disorders.